Upcoming Webinars: 2018Webinar

Life Sciences Webinar Series Library

Upcoming Webinars

Be sure to look for additional Life Sciences topics in 2018!

Past Webinars

Global Patent Strategies for Protecting Plants & Agricultural Products
Thursday, November 9, 2017
Presenters: Sansun Yeh, Ph.D.

This webinar will examine the various mechanisms available for protecting plants and other agricultural products in the U.S. (such as plant patents, utility patents, and plant variety protection certificates) as well as in other jurisdictions outside the U.S. Attorney Sansun Yeh, Ph.D., will explain the differences between the various forms of protection and provide recommendations and strategic guidance on maximizing protection for such inventions.

Click here to listen to the webinar.

Drug Repurposing
Wednesday, November 1, 2017

Repurposing of drugs is quickly becoming a fast growing market expected to reach over $30 billion worldwide by 2020. In this webinar, we will discuss what drug repurposing is, reasons for repurposing, the main players in the industry, and the scientific, intellectual property, and regulatory opportunities and challenges associated with such products in the U.S., Europe, and Japan. Additionally, some legislative proposals directed towards repurposing will be examined.

Click here to listen to the webinar.

“Best Practices for NDA’s and MTA’s in Collaborative Transactions”
Thursday, August 31, 2017
Presenters: Jeffrey D. Peterson

When companies collaborate, confidentiality and material transfer agreements are commonly used to protect each party's confidential information and proprietary materials that may be shared. In this presentation, attorney Jeffrey D. Peterson will discuss the common issues and “traps” found in standard confidentiality, non-disclosure, and material transfer agreements, and discuss best practices in drafting and negotiating such agreements.

Click here to listen to the webinar.

“Update on Biosimilars Litigation”
Wednesday, July 12, 2017

In this webinar, we will explore the Supreme Court’s Amgen v. Sandoz decision and its implications for litigation under the fledgling biosimilars regime in the United States. The presentation will also include an update on emerging trends in biosimilars litigation.

Click here to listen to the webinar.

"Best Practices in Chemical Patent Prosecution, Part 3 – Obviousness"
Tuesday, May 9, 2017

In this webinar, we will review recent case law concerning obviousness and its impact on prosecution of claims in the life science space.

Click here to listen to the webinar.

"An Overview of the 21st Century Cures Act"
Thursday, February 23, 2017
Presented by: Seth A. Mailhot

In this webinar, attorney Seth Mailhot will provide an overview of the 21st Century Cures Act, which was over two years in the making and will affect a wide swath of the U.S. healthcare industry.

Click here to listen to the webinar.

"Royalty Structures and Considerations for Life Sciences and Pharmaceutical Products"
Monday, October 10, 2016
Presented by: Jeffrey D. Peterson & Sansun Yeh, Ph.D.

This webinar will discuss issues and considerations when developing royalty models for the licensing of patented pharmaceutical compositions, biotechnology tools, drug discovery tools and other life sciences technologies. Presenters Jeffrey D. Peterson & Sansun Yeh, Ph.D. will also address different licensing models and associated legal issues.

Click here to listen to the webinar.

"An Update on Patentable Subject Matter in Life Sciences"
Wednesday, August 10, 2016

The Supreme Court and the Court of Appeals for the Federal Circuit have issued decisions related to patentable subject matter involving laws of nature and/or natural phenomena. In addition, the U.S. Patent and Trademark Office recently issued updated guidelines on subject matter eligibility in the Life Sciences. In this webinar, presenters will review recent case law concerning the patent eligibility of such subject matter and its impact on the life sciences industry and provide strategies for avoiding and overcoming such rejections.

Click here to listen to the webinar.

"An Unpredictable Art - AIA Trial Proceedings in the Chemical and Biological Sciences"
Wednesday, June 8, 2016

This webinar will focus on substantive issues and strategic considerations as they relate to the IPR proceedings initiated in the Chemical and Bio/Pharma technology centers. We will discuss key trends and decisions stemming from the IPR proceedings.

Click here to listen to the webinar.

"Foreign Filing Restrictions and Licenses"
Date: Wednesday, May 4, 2016

Commerce, inventions and product development often take place on an international scale in today’s day and age. In this webinar, our presenter will examine foreign filing restrictions in the U.S. and globally, including countries such as China, India, Russia, Great Britain and Germany. This presentation will cover the steps required to comply with local filing restrictions and to correctly apply for patent protection for inventions developed on an international scale, including requesting foreign filing licenses. 

Click here to listen to the webinar.

"Best Practices in Chemical Patent Prosecution Part 2: Clarity, Enablement and Written Description"
Wednesday, April 13, 2016
Presented by: Joseph M. Pletcher, Ph.D. & Wei Yan

This webinar will address pitfalls in drafting and prosecuting domestic and international patent applications relating to chemical compounds, compositions and methods of use.  Presenters Joseph M. Pletcher, Ph.D.and Wei Yan, Ph.D. will discuss the support, enablement and clarity rejections commonly encountered in the chemical space.

Click here to listen to the webinar.

"IP Security Interests – Navigating Claims on IP Ownership"
Wednesday, December 9, 2015 
Presented by: Jeffrey D. Peterson & Ann Ustad Smith

Many companies’ most valuable property to use as collateral for a loan are their patents, trademarks and copyrights. Lenders secure obligations of debtors using more than just traditional tangible assets as collateral since intellectual property rights have become more integral and valuable aspects of debtors’ assets. We will discuss how security interests for patents, trademarks and copyrights are properly perfected and recorded, how to perform due diligence on such interests, as well as the impact of such security interests on asset purchases, sales and licenses.

Click here to listen to the webinar. 

back to top